PCN46 A COST UTILITY ANALYSIS OF MAINTENANCE RITUXIMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY FOLLICULAR NON HODGKINS LYMPHOMA (NHL) IN THE UNITED KINGDOM
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65204-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)65204-7/fulltext
Section Title :
Section Order :
363
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65204-7&doi=10.1016/S1098-3015(10)65204-7